Ariadna Mendoza‐Naranjo

2.0k total citations
31 papers, 1.6k citations indexed

About

Ariadna Mendoza‐Naranjo is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ariadna Mendoza‐Naranjo has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ariadna Mendoza‐Naranjo's work include Immunotherapy and Immune Responses (9 papers), Connexins and lens biology (7 papers) and Immune Cell Function and Interaction (6 papers). Ariadna Mendoza‐Naranjo is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Connexins and lens biology (7 papers) and Immune Cell Function and Interaction (6 papers). Ariadna Mendoza‐Naranjo collaborates with scholars based in United Kingdom, Chile and United States. Ariadna Mendoza‐Naranjo's co-authors include Flavio Salazar‐Onfray, Mercedes López, Ricardo B. Maccioni, Christian González‐Billault, Cristián Pereda, Karthick Vishwanathan, Marcos Ramírez, Myung‐Ju Ahn, Andy Brown and Andrés Tittarelli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Ariadna Mendoza‐Naranjo

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariadna Mendoza‐Naranjo United Kingdom 21 614 601 455 415 166 31 1.6k
Rachel A. Altura United States 25 1.3k 2.1× 590 1.0× 193 0.4× 270 0.7× 165 1.0× 48 1.9k
Katherine Fishwick United Kingdom 14 963 1.6× 491 0.8× 210 0.5× 676 1.6× 137 0.8× 19 2.1k
Selen C. Muratoglu United States 21 848 1.4× 244 0.4× 231 0.5× 206 0.5× 140 0.8× 33 1.5k
Christina Jamieson United States 19 665 1.1× 708 1.2× 275 0.6× 734 1.8× 63 0.4× 43 1.8k
Michael J. Flister United States 22 758 1.2× 599 1.0× 161 0.4× 213 0.5× 137 0.8× 53 1.6k
Claudia A. Dumitru Germany 24 767 1.2× 819 1.4× 191 0.4× 992 2.4× 155 0.9× 52 2.3k
Lauri Miller United States 12 998 1.6× 444 0.7× 348 0.8× 273 0.7× 107 0.6× 16 2.1k
Sadna Budhu United States 21 507 0.8× 936 1.6× 226 0.5× 1.2k 2.8× 83 0.5× 60 2.1k
Masanori Naito Japan 19 693 1.1× 413 0.7× 205 0.5× 372 0.9× 102 0.6× 55 1.7k
Jessica Pruessmeyer Germany 14 611 1.0× 356 0.6× 119 0.3× 252 0.6× 110 0.7× 15 1.3k

Countries citing papers authored by Ariadna Mendoza‐Naranjo

Since Specialization
Citations

This map shows the geographic impact of Ariadna Mendoza‐Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariadna Mendoza‐Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariadna Mendoza‐Naranjo more than expected).

Fields of papers citing papers by Ariadna Mendoza‐Naranjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariadna Mendoza‐Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariadna Mendoza‐Naranjo. The network helps show where Ariadna Mendoza‐Naranjo may publish in the future.

Co-authorship network of co-authors of Ariadna Mendoza‐Naranjo

This figure shows the co-authorship network connecting the top 25 collaborators of Ariadna Mendoza‐Naranjo. A scholar is included among the top collaborators of Ariadna Mendoza‐Naranjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariadna Mendoza‐Naranjo. Ariadna Mendoza‐Naranjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sahasranaman, Srikumar, Xianbin Tian, Ying Fei Li, et al.. (2025). Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact. Clinical and Translational Science. 18(5). e70221–e70221. 3 indexed citations
2.
Li, Bob T., Funda Meric‐Bernstam, Soham D. Puvvada, et al.. (2021). A phase 2, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of solid tumors harboring specific HER2-activating mutations (DESTINY-PanTumor01).. Journal of Clinical Oncology. 39(15_suppl). TPS3162–TPS3162. 4 indexed citations
3.
Hughes, John, Hilary Plant, Ariadna Mendoza‐Naranjo, et al.. (2021). A feasibility trial of acupuncture in cancer patients undergoing radiotherapy treatment. Complementary Therapies in Clinical Practice. 43. 101372–101372. 1 indexed citations
4.
5.
Ahn, Myung‐Ju, Chao‐Hua Chiu, Ying Cheng, et al.. (2019). Osimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC: The AURA LM study. Annals of Oncology. 30. ii48–ii48. 2 indexed citations
6.
Ahn, Myung‐Ju, Chao‐Hua Chiu, Ying Cheng, et al.. (2019). Osimertinib for Patients With Leptomeningeal Metastases Associated With EGFR T790M-Positive Advanced NSCLC: The AURA Leptomeningeal Metastases Analysis. Journal of Thoracic Oncology. 15(4). 637–648. 100 indexed citations
7.
Ahn, Myung‐Ju, Chao‐Hua Chiu, Ying Cheng, et al.. (2018). Osimertinib for patients (pts) with leptomeningeal metastases (LM) associated with EGFRm advanced NSCLC. Annals of Oncology. 29. ix151–ix152. 1 indexed citations
8.
Tittarelli, Andrés, Fabián Tempio, María Alejandra Gleisner, et al.. (2015). Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity. British Journal of Cancer. 113(2). 259–267. 58 indexed citations
9.
Mendoza‐Naranjo, Ariadna, Amal M. El-Naggar, Daniel Wai, et al.. (2013). ERBB 4 confers metastatic capacity in Ewing sarcoma. EMBO Molecular Medicine. 5(7). 1087–1102. 71 indexed citations
10.
Mendoza‐Naranjo, Ariadna, Antonio E. Serrano, Chiuhui Mary Wang, et al.. (2012). Overexpression of the gap junction protein Cx43 as found in diabetic foot ulcers can retard fibroblast migration. Cell Biology International. 36(7). 661–667. 52 indexed citations
11.
Mendoza‐Naranjo, Ariadna, Antonio E. Serrano, Rebecca Hu, et al.. (2012). Targeting Cx43 and N-Cadherin, Which Are Abnormally Upregulated in Venous Leg Ulcers, Influences Migration, Adhesion and Activation of Rho GTPases. PLoS ONE. 7(5). e37374–e37374. 52 indexed citations
12.
Tittarelli, Andrés, Fermín E. González, Marcos Ramírez, et al.. (2011). Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells. Clinical Cancer Research. 17(8). 2474–2483. 70 indexed citations
13.
Bouma, Gerben, Ariadna Mendoza‐Naranjo, Michael P. Blundell, et al.. (2011). Cytoskeletal remodeling mediated by WASp in dendritic cells is necessary for normal immune synapse formation and T-cell priming. Blood. 118(9). 2492–2501. 57 indexed citations
14.
Mendoza‐Naranjo, Ariadna, et al.. (2008). Gap Junctions as Therapeutic Targets in Brain Injury Following Hypoxia- Ischemia. PubMed. 3(3). 209–215. 8 indexed citations
15.
Mendoza‐Naranjo, Ariadna, Pablo J. Sáez, C. Christian Johansson, et al.. (2007). Functional Gap Junctions Facilitate Melanoma Antigen Transfer and Cross-Presentation between Human Dendritic Cells. The Journal of Immunology. 178(11). 6949–6957. 88 indexed citations
16.
Mendoza‐Naranjo, Ariadna, Christian González‐Billault, & Ricardo B. Maccioni. (2007). Aβ1-42 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases. Journal of Cell Science. 120(2). 279–288. 92 indexed citations
17.
Salazar‐Onfray, Flavio, Mercedes López, & Ariadna Mendoza‐Naranjo. (2007). Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape. Cytokine & Growth Factor Reviews. 18(1-2). 171–182. 156 indexed citations
18.
López, Mercedes, Ariadna Mendoza‐Naranjo, Cristián Pereda, et al.. (2006). The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines. Immunobiology. 211(1-2). 127–136. 29 indexed citations
19.
Maccioni, Ricardo B., et al.. (2004). Biological Markers of Alzheimers Disease and Mild Cognitive Impairment. Current Alzheimer Research. 1(4). 307–314. 34 indexed citations
20.
Otth, Carola, et al.. (2003). Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer’s disease. Neuroreport. 14(18). 2403–2409. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel A. Altura Breakdown of academic impact, for papers by Katherine Fishwick Breakdown of academic impact, for papers by Selen C. Muratoglu Breakdown of academic impact, for papers by Christina Jamieson Breakdown of academic impact, for papers by Michael J. Flister Breakdown of academic impact, for papers by Claudia A. Dumitru Breakdown of academic impact, for papers by Lauri Miller Breakdown of academic impact, for papers by Sadna Budhu Breakdown of academic impact, for papers by Masanori Naito Breakdown of academic impact, for papers by Jessica Pruessmeyer
Rankless by CCL
2026